Cargando…

Combinations of EGFR and MET inhibitors reduce proliferation and invasiveness of mucosal melanoma cells

Mucosal melanoma (MM) is a very rare and aggressive type of cancer for which immunotherapy or targeted therapy such as BRAF/MEK inhibitors, used in cutaneous melanoma, usually fail. Due to our earlier experience showing the high effectiveness of epidermal growth factor receptor (EGFR) and hepatocyte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Simiczyjew, Aleksandra, Wądzyńska, Justyna, Kot, Magdalena, Ziętek, Marcin, Matkowski, Rafał, Hoang, Mai P., Donizy, Piotr, Nowak, Dorota
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538264/ https://www.ncbi.nlm.nih.gov/pubmed/37679999 http://dx.doi.org/10.1111/jcmm.17935

Ejemplares similares

Melanoma cells induce dedifferentiation and metabolic changes in adipocytes present in the tumor niche
por: Simiczyjew, Aleksandra, et al.
Publicado: (2023)

Combination of Selected MET and EGFR Inhibitors Decreases Melanoma Cells’ Invasive Abilities
por: Simiczyjew, Aleksandra, et al.
Publicado: (2019)

Expression level of EGFR and MET receptors regulates invasiveness of melanoma cells
por: Pietraszek‐Gremplewicz, Katarzyna, et al.
Publicado: (2019)

The Influence of Tumor Microenvironment on Immune Escape of Melanoma
por: Simiczyjew, Aleksandra, et al.
Publicado: (2020)

Melanoma stimulates the proteolytic activity of HaCaT keratinocytes
por: Mazurkiewicz, Justyna, et al.
Publicado: (2022)

Hypoxia and Extracellular Acidification as Drivers of Melanoma Progression and Drug Resistance
por: Dratkiewicz, Ewelina, et al.
Publicado: (2021)

Stromal Cells Present in the Melanoma Niche Affect Tumor Invasiveness and Its Resistance to Therapy
por: Mazurkiewicz, Justyna, et al.
Publicado: (2021)

Melanoma cells with diverse invasive potential differentially induce the activation of normal human fibroblasts
por: Mazurkiewicz, Justyna, et al.
Publicado: (2022)

Characterization of Melanoma Cell Lines Resistant to Vemurafenib and Evaluation of Their Responsiveness to EGFR- and MET-Inhibitor Treatment
por: Dratkiewicz, Ewelina, et al.
Publicado: (2019)

High Percentage of ADAM-10 Positive Melanoma Cells Correlates with Paucity of Tumor-Infiltrating Lymphocytes but Does Not Predict Prognosis in Cutaneous Melanoma Patients
por: Donizy, Piotr, et al.
Publicado: (2015)

Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients
por: Donizy, Piotr, et al.
Publicado: (2015)

Alpha-Enolase (ENO1) Correlates with Invasiveness of Cutaneous Melanoma—An In Vitro and a Clinical Study
por: Hippner, Miriam, et al.
Publicado: (2022)

Combination of EGFR Inhibitor Lapatinib and MET Inhibitor Foretinib Inhibits Migration of Triple Negative Breast Cancer Cell Lines
por: Simiczyjew, Aleksandra, et al.
Publicado: (2018)

Nucleoli cytomorphology in cutaneous melanoma cells – a new prognostic approach to an old concept
por: Donizy, Piotr, et al.
Publicado: (2017)

PARP1 as a Marker of an Aggressive Clinical Phenotype in Cutaneous Melanoma—A Clinical and an In Vitro Study
por: Kupczyk, Piotr, et al.
Publicado: (2021)

Severe complications of nivolumab monotherapy in an adolescent with malignant melanoma
por: Grzegorczyk, Aleksandra, et al.
Publicado: (2023)

Golgi-Related Proteins GOLPH2 (GP73/GOLM1) and GOLPH3 (GOPP1/MIDAS) in Cutaneous Melanoma: Patterns of Expression and Prognostic Significance
por: Donizy, Piotr, et al.
Publicado: (2016)

Introduction of a pilot program to measure and improve the clinical care of melanoma patients in the Lower Silesian Voivodeship in Poland: a report of 20 months experience
por: Ziętek, Marcin, et al.
Publicado: (2022)

Upregulation of FOXP1 is a new independent unfavorable prognosticator and a specific predictor of lymphatic dissemination in cutaneous melanoma patients
por: Donizy, Piotr, et al.
Publicado: (2018)

An analysis of clinical effectiveness of electrochemotherapy in the treatment of advanced metastatic malignant melanoma performed in the eastern part of Central Europe: a single-centre experience
por: Ziętek, Marcin, et al.
Publicado: (2022)

ERM/Rho protein expression in ductal breast cancer: a 15 year follow-up
por: Halon, Agnieszka, et al.
Publicado: (2013)

Outcomes of Patients with Metastatic Melanoma—A Single-Institution Retrospective Analysis
por: Szatkowska, Lidia, et al.
Publicado: (2022)

Incidence of different types of cancer in the follow-up period after primary diagnosis and treatment of melanoma. Single-centre 4-year follow-up on a population of 709 patients
por: Ziętek, Marcin, et al.
Publicado: (2023)

Gefitinib or lapatinib with foretinib synergistically induce a cytotoxic effect in melanoma cell lines
por: Dratkiewicz, Ewelina, et al.
Publicado: (2018)

Biological Aggressiveness of Subclinical No-Mass Ductal Carcinoma In Situ (DCIS) Can Be Reflected by the Expression Profiles of Epithelial-Mesenchymal Transition Triggers
por: Szynglarewicz, Bartlomiej, et al.
Publicado: (2018)

Up-Regulation of PARP1 Expression Significantly Correlated with Poor Survival in Mucosal Melanomas
por: Donizy, Piotr, et al.
Publicado: (2020)

Augmented expression of Polo-like kinase 1 is a strong predictor of shorter cancer-specific overall survival in early stage breast cancer at 15-year follow-up
por: Donizy, Piotr, et al.
Publicado: (2016)

HER-2 Expression in Immunohistochemistry Has No Prognostic Significance in Gastric Cancer Patients
por: Halon, Agnieszka, et al.
Publicado: (2012)

MRP2 (ABCC2, cMOAT) expression in nuclear envelope of primary fallopian tube cancer cells is a new unfavorable prognostic factor
por: Halon, Agnieszka, et al.
Publicado: (2012)

Involvement of β- and γ-actin isoforms in actin cytoskeleton organization and migration abilities of bleb-forming human colon cancer cells
por: Simiczyjew, Aleksandra, et al.
Publicado: (2017)

Chronic Active T-Cell Mediated Kidney Rejection as a Clinically Significant Type of Allograft Loss?
por: Mizera, Jakub, et al.
Publicado: (2022)

The report and analysis concerning the usefulness of basic telemedicine tools in the skin cancer diagnostic screening process during COVID-19 pandemics
por: Ziętek, Marcin, et al.
Publicado: (2022)

Amelanotic Uveal Melanomas Evaluated by Indirect Ophthalmoscopy Reveal Better Long-Term Prognosis Than Pigmented Primary Tumours—A Single Centre Experience
por: Markiewicz, Anna, et al.
Publicado: (2022)

The effect of YAP expression in tumor cells and tumor stroma on the prognosis of patients with squamous cell carcinoma of the oral cavity floor and oral surface of the tongue
por: Szelachowska, Jolanta, et al.
Publicado: (2019)

MET-EGFR dimerization in lung adenocarcinoma is dependent on EGFR mtations and altered by MET kinase inhibition
por: Ortiz-Zapater, Elena, et al.
Publicado: (2017)

Varying Effects of EGF, HGF and TGFβ on Formation of Invadopodia and Invasiveness of Melanoma Cell Lines of Different Origin
por: Makowiecka, A., et al.
Publicado: (2016)

Effect of overexpression of β- and γ-actin isoforms on actin cytoskeleton organization and migration of human colon cancer cells
por: Simiczyjew, Aleksandra, et al.
Publicado: (2014)

MET Gene Amplification and MET Receptor Activation Are Not Sufficient to Predict Efficacy of Combined MET and EGFR Inhibitors in EGFR TKI-Resistant NSCLC Cells
por: Presutti, Dario, et al.
Publicado: (2015)

MDM2, MDM4 and EGFR Amplifications and Hyperprogression in Metastatic Acral and Mucosal Melanoma
por: Forschner, Andrea, et al.
Publicado: (2020)

EGFR/Met association regulates EGFR TKI resistance in breast cancer
por: Mueller, Kelly L, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_73e7b18e5e78c58p7gu9l8gr2t